MON-87427-7
EU register of genetically modified food and feed.
Event | MON 87427 |
Authorisation holder Name |
Bayer Agriculture BV, Belgium representing Bayer CropScience LP, United States |
Authorisation holder Address |
Bayer Agriculture BV Scheldelaan 460, 2040 Antwerp, Belgium On behalf of Bayer CropScience LP, 800 N. Lindbergh Boulevard, St. Louis, Missouri 63167 – United States. |
Products |
1) Foods and food ingredients containing, consisting of, or produced from MON-87427-7 maize
2) Feed containing, consisting of, or produced from MON-87427-7 maize 3) Products other than food and feed containing or consisting of MON-87427-7 maize for the same uses as any other maize with the exception of cultivation |
Designation | The genetically modified MON-87427-7 maize expresses the CP4 EPSPS protein which confers tissue-selective tolerance to glyphosate herbicides. The CP4 EPSPS expression is absent or limited in male reproductive tissues, which eliminates or reduces the need for detasseling when MON-87427-7 is used as female parent in hybrid maize seed production. |
Labelling |
For the purposes of the specific labelling requirements laid down in Article 13(1) and Article 25(2) of Regulation (EC) No 1829/2003, and in Article 4(6) of Regulation (EC) No 1830/2003, the ’name of the organism’ shall be ’maize’;
The words 'not for cultivation' shall appear on the label of and in documents accompanying products containing or consisting of MON-87427-7 maize with the exception of products referred to in point (a) of Article 2. |
Method for detection |
Event specific real-time PCR based method for the quantification of MON-87427-7 maize;
Validated by the EU Reference Laboratory established under Regulation (EC) No 1829/2003, published at: URL: http://gmo-crl.jrc.ec.europa.eu/statusofdossiers.aspx |
Reference material | AOCS 0512-A and AOCS 0406-A are accessible via the American Oil Chemists Society at http://www.aocs.org/LabServices/content.cfm?ItemNumber=19248 |
Unique identifier | MON-87427-7 |
Annex II to the Cartagena Protocol | https://bch.cbd.int/database/record.shtml?documentid=109584 |
Conditions or restrictions on the placing on the market | Not required |
Monitoring plan | Monitoring plan for environmental effects conforming with Annex VII to Directive 2001/18/EC |
Post-market monitoring requirements | Not required |
Date of authorisation | 04/12/2015 |
Legal base |
Art. 7(3) and 19(3) of the Regulation (EC) No 1829/2003
Commission Decision 2015/2281/UE of 4 December 2015 Amended by Commission Implementing Decision (EU) 2019/1579 of 18 September 2019 Amended by Commission Implementing Decision (EU) 2021/184 of 12 February 2021 |
Authorisation expiration date | 03/12/2025 |
Further information on risk assessment |
Opinion of the European Food Safety Authority: http://www.efsa.europa.eu/en/efsajournal/pub/4130 |